Wednesday, July 29, 2026

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

Korean Researchers Achieve Breakthrough in High-Frequency Axion Detection

Researchers led by Dr. Yoon Seong-woo have enhanced axion detection sensitivity in high-mass regions, advancing dark matter studies.

Unlocking Opportunities: iMarket Korea Partners for 60 Million USD Texas Tech Park Development

iMarketKorea partners with Korea Trade Insurance and Citibank to develop a high-tech industrial complex in Texas, enhancing U.S. presence.

CARS

TECH

FUTURE

HEALTH